Hypertrophic cardiomyopathy guidelines add drug categories to support more exercise

A medical illustration of hypertrophic cardiomyopathy

Updates to national guidelines for the management of hypertrophic cardiomyopathy (HCM) support the use of cardiac myosin inhibitors in certain circumstances, providing a green light for more intensive physical activity …

Read more

Affinia Therapeutics Presents Preclinical Data from Novel Cardiotropic and BBB-Permeable AAV Capsids Program for Inherited Cardiomyopathy and Sporadic ALS at the American Society for Gene and Cell Therapy 2024 Annual Meeting

Novel cardiac capsid transduces more than 90% of cardiomyocytes in non-human primates (NHP) and off-targets the liver and dorsal root ganglia (DRG); shows safety and efficacy in mouse model of …

Read more

Study stratifies risk of dilated cardiomyopathy in asymptomatic genetic carriers for first time

Study stratifies risk of dilated cardiomyopathy in asymptomatic genetic carriers for first time

MRI of the heart in a patient with dilated cardiomyopathy (left) and in a patient without heart disease (right). People with dilated cardiomyopathy have an enlarged heart with a reduced …

Read more